HAVN Life Sciences Stock Price, News & Analysis (OTCMKTS:HAVLF) $0.01 -0.02 (-57.14%) (As of 04:20 PM ET) Add Compare Share Share Today's Range$0.01▼$0.0250-Day Range$0.01▼$0.0352-Week Range$0.00▼$0.10Volume2,182 shsAverage Volume14,897 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartHeadlinesShort InterestStock AnalysisChartHeadlinesShort Interest About HAVN Life Sciences Stock (OTCMKTS:HAVLF)HAVN Life Sciences Inc., a biotechnology company, engages in the research and development of psychopharmacological products from plants and fungi. The Company also focuses on developing methodologies for the standardize and quality-controlled extraction of psychoactive compounds from plants and fungi, including Psilocybe spp. mushrooms; and the genera directive compounds, such as psilocybin, psilocin, and baeocystin, as well as the development of natural health care products from non-regulated compounds. The company was incorporated in 2020 and is headquartered in Richmond, Canada.Read More HAVLF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart HAVLF Stock News HeadlinesNovember 10, 2023 | finance.yahoo.comCanadian Investment Regulatory Organization Trading Halt - HAVNOctober 2, 2023 | forbes.comDiscovering Life’s Story: Biology’s Beginnings By Joy Hakim— ReviewNovember 29, 2023 | Autonomix (Ad)[Investor Alert] Potential Breakthrough Medical Tech Investment OpportunityAutonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.comSeptember 4, 2023 | sports.yahoo.comLife science founder to land £120m payout from private equity swoopJune 28, 2023 | finance.yahoo.comHAVN.CN - HAVN Life Sciences Inc.February 8, 2023 | investing.comHAVN Life Sciences Inc (HAVN)September 22, 2022 | yahoo.comHeavy storms expected across Arizona through Thursday. Here's what to knowSeptember 20, 2022 | finance.yahoo.comHAVN Life Provides Corporate UpdateNovember 29, 2023 | Autonomix (Ad)[Investor Alert] Potential Breakthrough Medical Tech Investment OpportunityAutonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.comSeptember 14, 2022 | finance.yahoo.comHAVN Life Sciences Inc. (HAVLF)August 3, 2022 | finance.yahoo.comIIROC Trading Halt - HAVNAugust 3, 2022 | finance.yahoo.comIIROC Trade Resumption - HAVNAugust 1, 2022 | finanznachrichten.deHAVN Life Sciences Inc.: HAVN Life Announces a 30:1 Consolidation of its Common SharesJuly 29, 2022 | finance.yahoo.comHAVN Life Announces a 30:1 Consolidation of its Common SharesJune 28, 2022 | seekingalpha.comHAVN Life enters supply agreement with MPB GroupJune 28, 2022 | benzinga.comHAVN Life Enters Supply Agreement with MPB Group Inc.June 22, 2022 | finance.yahoo.comHAVN Life To Be Featured On Viewpoint with Dennis QuaidJune 14, 2022 | finance.yahoo.comHAVN Life Announces Changes to the Board of DirectorsJune 6, 2022 | finance.yahoo.comHAVN Life to Present at Upcoming LD Micro Invitational XIIMay 16, 2022 | finance.yahoo.comHAVN Life Announces Strategic Partnership with Non-Profit Coalition, TheraPsilMay 11, 2022 | finance.yahoo.comHAVN Life Secures Supply Agreement with Atman RetreatsMay 2, 2022 | finance.yahoo.comHAVN Life Ships First White Label Order to Distribution Partner Woke Pharmaceuticals in AustraliaApril 30, 2022 | finance.yahoo.comHAVN Life Sciences Inc. to Present at the Planet MicroCap Showcase 2022 in Las Vegas on Wednesday, May 4, 2022April 13, 2022 | financialpost.comHAVN Life Launches the Brain Evolve SeriesMarch 22, 2022 | seekingalpha.comHAVN Life expands supply agreement with Mycotopia TherapiesMarch 22, 2022 | finance.yahoo.comHAVN Life Expands Supply Agreement with Mycotopia Therapies Inc.March 17, 2022 | finance.yahoo.comMycotopia Therapies, Inc. Expands Presence In The Registered Mushroom Sector With HAVN Life Sciences Inc.See More Headlines Receive HAVLF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for HAVN Life Sciences and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today11/29/2023Next Earnings (Estimated)1/15/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS Industry Biotechnology Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:HAVLF CUSIPN/A CIKN/A Webwww.havnlife.com PhoneN/AFaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Tim Moore (Age 64)Interim CFO, CEO & Chairman Comp: $126.05kMs. Jenna PozarChief Operations OfficerMr. Paul MoreControllerKey Competitors3SBioOTCMKTS:TRSBF60 Degrees PharmaceuticalsNASDAQ:SXTPWAbcamOTCMKTS:ABCZFAdociaOTCMKTS:ADOIFAgentixOTCMKTS:AGTXView All Competitors HAVLF Stock Analysis - Frequently Asked Questions How have HAVLF shares performed in 2023? HAVN Life Sciences' stock was trading at $0.0595 at the beginning of 2023. Since then, HAVLF shares have decreased by 79.8% and is now trading at $0.0120. View the best growth stocks for 2023 here. Are investors shorting HAVN Life Sciences? HAVN Life Sciences saw a decrease in short interest in November. As of November 15th, there was short interest totaling 100 shares, a decrease of 99.6% from the October 31st total of 27,600 shares. Based on an average trading volume of 600 shares, the days-to-cover ratio is presently 0.2 days. View HAVN Life Sciences' Short Interest. When is HAVN Life Sciences' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, January 15th 2024. View our HAVLF earnings forecast. When did HAVN Life Sciences' stock split? HAVN Life Sciences shares reverse split on the morning of Wednesday, August 3rd 2022. The 1-30 reverse split was announced on Wednesday, August 3rd 2022. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, August 3rd 2022. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split. How do I buy shares of HAVN Life Sciences? Shares of HAVLF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. This page (OTCMKTS:HAVLF) was last updated on 11/29/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HAVN Life Sciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.